Home > Healthcare & Medical Devices > U.S. Ophthalmic Sutures Market

U.S. Ophthalmic Sutures Market Size By Type (Natural, Synthetic), By Material (Nylon, Polyproplene, Silk, PGA), By Coating (Coated, Uncoated), By Material Structure (Monofilament, Multifilament/Braided) By Absorption (Absorbable, Non-absorbable), By Application (Corneal Transplantation Surgery, Cataract Surgery, Vitrectomy, Iridectomy, Oculoplastic Surgery), By End-use (Hospitals, Ambulatory Surgical Centers [ASCs]), Industry Analysis Report, Application Potential, Competitive Market Share & Forecast, 2023 – 2032

  • Report ID: GMI4517
  • Published Date: Dec 2022
  • Report Format: PDF

Industry Statistics

U.S. Ophthalmic Sutures Market Size was valued at more than USD 296 million in 2022 and is expected to observe a 5.5% CAGR through 2032. Growing prevalence of eye diseases in the U.S. is anticipated to expedite the market growth in the coming years.

Get more details on this report - Request Free Sample PDF

Disorders such as cataract, glaucoma, and detached retina have added to the eye disease burden in the region. As per the National Eye Institute, around 24 million Americans are presently suffering from cataract and an estimated 38.7 million will be affected by the disease by 2030. Usually, surgeries are recommended to treat such severe eye diseases to improve vision. Hence, these diseases are contributing to the demand for ophthalmic suture products that provide optimum outcomes in related surgical procedures.

Postoperative complications associated with ophthalmic procedures to hamper U.S. ophthalmic sutures market progression

The postoperative complications related to ophthalmic surgeries may have a negative impact on the industry growth. Lack of proper training and essential expertise can be very risky for the patient undergoing surgery. The possible complications include bleeding, inflammation inside the eye, retinal detachment, infection, etc. According to the American Academy of Ophthalmology, immediate complications related to eye surgeries are allergic reactions to the antibiotic drop, discomfort and swelling of the eyelid, and increased intraocular pressure, among others.

Increasing preference for natural ophthalmic structures to drive industry demand

Get more details on this report - Request Free Sample PDF

U.S. natural ophthalmic sutures market share is expected to reach around USD 163 million through 2032. These sutures offer adequate strength, can perform self-degradation absorption, and possess non-irritating and carcinogenic characteristics. Moreover, these natural sutures are easy to produce at low cost along with mass production. Natural ophthalmic sutures are considerably recommended in related surgical procedures attributable to good absorption, strong pull, and support wound healing characteristics. Hence, the regional product demand will be influenced by these distinct product traits.

Need for less-friction properties to promote adoption of coated sutures in the U.S.

U.S. ophthalmic sutures market share from the coated segment is expected to grow with more than 5% CAGR by 2032. Suture coating is known to lessen friction for ease of tissue passage and provides enhanced suture flexibility. This coating material delivers accurate consistent suture tension and holds tensile strength and can also be coated with antibiotics that make them more infection resistant. Coating serves the purpose of modifying the surface that enhances precision and penetration. The current antibiotics used by market players are showing sufficient effectiveness against bacterial resistance. Thus, these coated sutures can be touted as evaluated promising tools in the fight against surgical site infections.

Increasing count of cataract surgeries to influence market outlook

The industry size from the cataract surgery segment is anticipated to record more than 5.5% CAGR through 2032. Growing occurrence of cataract disease is driving the market growth. For instance, in 2021, around 10,000 U.S. cataract surgeons performed around 4 million procedures in the U.S. Some of the key variables driving the market growth are rising accessibility to innovative technologies that boost the quality of cataract surgery coupled with the presence of board-certified skilled surgeons. Moreover, continuous advancements and development in ophthalmic sutures used in these procedures will positively impact the industry expansion.

Hospitals to see increased patient footfall for surgeries in the U.S.

Get more details on this report - Request Free Sample PDF

U.S. ophthalmic sutures market share from the hospital segment held dominant market share in 2022 and is projected to touch USD 297 million through 2032. Increasing number of ophthalmic surgical procedures performed at hospital settings will foster the segmental progression. Moreover, surging number of patients that require critical care along with rising availability of better healthcare infrastructure will propel the market growth. The ease of access to a wide range of surgical treatments, medical evaluation for various ailments, and hygienic conditions in the country are some factors contributing to the industry progression.

Strategic initiatives to reinforce competitive sphere of U.S. ophthalmic sutures market

Some prominent companies operating in the regional market include Medtronic, Mani, Corzamedical, Teleflex Incorporated, Ethicon, B Braun Melsungen AG, and DemeTECH Corporation among others. These players are turning to various strategies for increased global presence. In June 2021, Ethicon announced the approval for the use of Ethicon Plus Sutures in surgeries within the National Health Service (NHS). These sutures provide antibacterial protection and are recommended as part of a bundle of care for preventing surgical site infection in the NHS for people that need wound closure after a surgical procedure. This recommendation represents a significant milestone for Ethicon and will help the company in strategically expanding into international markets.

Impact of COVID-19 pandemic on U.S. ophthalmic structures industry outlook

The recent outbreak of COVID-19 crisis had a negative impact on the U.S. ophthalmic sutures industry revenue in 2020. The year witnessed the highest incidence and death rates from coronavirus, with people preferring to avoid other treatments in health facilities. The U.S. announced a national emergency as well as a ban on all the elective surgical procedures across the outpatient and inpatient settings. For instance, in the U.S., the CovidSurge Collaborative estimated that over 4 million elective surgeries were canceled due to the coronavirus over the peak 12 weeks.  Such variables had impacted the growth of the market in several zones in the U.S.

U.S. ophthalmic sutures market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

By Type

  • Natural
  • Synthetic

By Material

  • Nylon
  • Polyproplene
  • Silk
  • PGA
  • Others

By Coating

  • Coated
  • Uncoated

By Material Structure

  • Monofilament
  • Multifilament/Braided

By Absorption

  • Absorbable
  • Non-absorbable

By Application

  • Cataract Surgery
  • Corneal Transplantation Surgery
  • Glucoma Surgery
  • Vitrectomy
  • Oculoplastic surgery
  • Others

By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others


Authors: Rupali Swain, Subodh Kharad

Frequently Asked Questions (FAQ) :

U.S. market for ophthalmic sutures was valued at over USD 296 million in 2022 and is projected to observe a 5.5% CAGR through 2032, owing to the growing prevalence of eye diseases in the region.
Demand for natural ophthalmic sutures in the U.S. is expected to reach around USD 163 million through 2032, thanks to the adequate strength, self-degradation absorption, and non-irritating carcinogenic characteristics of the product.
U.S. ophthalmic sutures industry share from the hospital segment is projected to reach USD 297 million through 2032, with better healthcare infrastructure and professional aid offered by these institutions.
Some prominent companies operating in the regional market include Medtronic, Mani, Corzamedical, Teleflex Incorporated, Ethicon, B Braun Melsungen AG, and DemeTECH Corporation among others.

Buy Now

Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 74
  • Countries covered: 1
  • Pages: 90
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount